These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29241838)

  • 21. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
    Madsen T; Schmidt EB; Christensen JH
    J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease.
    Barden A; O'Callaghan N; Burke V; Mas E; Beilin LJ; Fenech M; Irish AB; Watts GF; Puddey IB; Huang RC; Mori TA
    Nutrients; 2016 Mar; 8(3):175. PubMed ID: 27007392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
    Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
    Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial.
    Xu F; Fan W; Wang W; Tang W; Yang F; Zhang Y; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2019 Apr; 236(4):1273-1279. PubMed ID: 30519766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
    Kulkarni J; Gavrilidis E; Gwini SM; Worsley R; Grigg J; Warren A; Gurvich C; Gilbert H; Berk M; Davis SR
    JAMA Psychiatry; 2016 Sep; 73(9):947-54. PubMed ID: 27438995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate.
    Behdani F; Roudbaraki SN; Saberi-Karimian M; Tayefi M; Hebrani P; Akhavanrezayat A; Amlashi SV; Ferns GA; Ghayour-Mobarhan M
    Psychiatry Res; 2018 Mar; 261():243-247. PubMed ID: 29329042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial.
    Vaz JDS; Farias DR; Adegboye ARA; Nardi AE; Kac G
    BMC Pregnancy Childbirth; 2017 Jun; 17(1):180. PubMed ID: 28599630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.
    Findling RL; McKenna K; Earley WR; Stankowski J; Pathak S
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):327-42. PubMed ID: 23083020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consumption of echium oil increases EPA and DPA in blood fractions more efficiently compared to linseed oil in humans.
    Kuhnt K; Weiß S; Kiehntopf M; Jahreis G
    Lipids Health Dis; 2016 Feb; 15():32. PubMed ID: 26892399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.
    Smesny S; Milleit B; Schaefer MR; Hesse J; Schlögelhofer M; Langbein K; Hipler UC; Berger M; Cotter DR; Sauer H; McGorry PD; Amminger GP
    Schizophr Res; 2017 Oct; 188():110-117. PubMed ID: 28126360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
    Furukawa TA; Levine SZ; Tanaka S; Goldberg Y; Samara M; Davis JM; Cipriani A; Leucht S
    JAMA Psychiatry; 2015 Jan; 72(1):14-21. PubMed ID: 25372935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder.
    Cantillon M; Prakash A; Alexander A; Ings R; Sweitzer D; Bhat L
    Schizophr Res; 2017 Nov; 189():126-133. PubMed ID: 28215471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea.
    Park Y; Lee A; Shim SC; Lee JH; Choe JY; Ahn H; Choi CB; Sung YK; Bae SC
    J Nutr Biochem; 2013 Jul; 24(7):1367-72. PubMed ID: 23333088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary Buglossoides Arvensis Oil Increases Circulating n-3 Polyunsaturated Fatty Acids in a Dose-Dependent Manner and Enhances Lipopolysaccharide-Stimulated Whole Blood Interleukin-10-A Randomized Placebo-Controlled Trial.
    Lefort N; LeBlanc R; Surette ME
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28287415
    [No Abstract]   [Full Text] [Related]  

  • 36. 21 days of mammalian omega-3 fatty acid supplementation improves aspects of neuromuscular function and performance in male athletes compared to olive oil placebo.
    Lewis EJ; Radonic PW; Wolever TM; Wells GD
    J Int Soc Sports Nutr; 2015; 12():28. PubMed ID: 26085822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor.
    Lane HY; Lin CH; Green MF; Hellemann G; Huang CC; Chen PW; Tun R; Chang YC; Tsai GE
    JAMA Psychiatry; 2013 Dec; 70(12):1267-75. PubMed ID: 24089054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a supplementation of n-3 polyunsaturated fatty acids with or without fish gelatin on gene expression in peripheral blood mononuclear cells in obese, insulin-resistant subjects.
    Rudkowska I; Ponton A; Jacques H; Lavigne C; Holub BJ; Marette A; Vohl MC
    J Nutrigenet Nutrigenomics; 2011; 4(4):192-202. PubMed ID: 21876360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granisetron as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.
    Khodaie-Ardakani MR; Seddighi S; Modabbernia A; Rezaei F; Salehi B; Ashrafi M; Shams-Alizadeh N; Mohammad-Karimi M; Esfandiari GR; Hajiaghaee R; Akhondzadeh S
    J Psychiatr Res; 2013 Apr; 47(4):472-8. PubMed ID: 23375406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omega-3 fatty acids for a better mental state in working populations - Happy Nurse Project: A 52-week randomized controlled trial.
    Watanabe N; Matsuoka Y; Kumachi M; Hamazaki K; Horikoshi M; Furukawa TA
    J Psychiatr Res; 2018 Jul; 102():72-80. PubMed ID: 29627596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.